Pemetrexed for Injection, USP Now Available

Share Facebook icon Twitter icon Linkedin icon

Meitheal Pharmaceuticals (Meitheal) is pleased to announce we have launched Pemetrexed for Injection, USP in 100 mg per 10 mL vial in a single-dose vial and 500 mg per 50 mL vial in a single-dose vial.

Meitheal will offer Pemetrexed for Injection, USP in carton of 1 vial for both presentations.


Pemetrexed for Injection, USP is indicated in combination with pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous NSCLC, with no EGFR or ALK genomic tumor aberrations. For full prescribing information, and safety information, including boxed warning, please click on the following link

Learn more about Pemetrexed for Injection, USP.

This Website Uses Cookies

This website uses cookies to help give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and help us make improvements to our site. You can read more about our use of cookies in our Privacy Policy.

Manage Consent Preferences

Always Active

Necessary cookies enable core functionality such as security and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

These cookies are set to provide quantitative measures of website visitors. Information collected with these cookies is used in operations to measure website performance. With the usage of these cookies we are able to count visits and traffic sources to improve our site. The data is collected in a way that does not directly identify anyone.
Accept all cookies Confirm my choices